Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response

Glioblastoma multiforme (GBM) is the most common and most aggressive type of primary brain cancer. Since median overall survival with multimodal standard therapy is only 15 months, there is a clear need for additional effective and long-lasting treatments. Dendritic cell (DC) vaccination is an exper...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Immunotargets Ther
Asıl Yazarlar: Dejaegher, Joost, Van Gool, Stefaan, De Vleeschouwer, Steven
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2014
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4918234/
https://ncbi.nlm.nih.gov/pubmed/27471700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S40121
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller